Liberty Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Hold
1,715
0.03% 239
2026
Q1
$239K Sell
1,715
-122
-7% -$17.1K 0.03% 239
2025
Q4
$225K Sell
1,837
-121
-6% -$14.7K 0.03% 227
2025
Q3
$217K Sell
1,958
-14
-0.7% -$1.59K 0.03% 226
2025
Q2
$219K Sell
1,972
-318
-14% -$33.8K 0.03% 211
2025
Q1
$257K Buy
+2,290
New +$236K 0.05% 130
2024
Q4
Sell
-3,242
Closed -$272K 230
2024
Q3
$272K Buy
3,242
+63
+2% +$4.81K 0.05% 168
2024
Q2
$218K Buy
+3,179
New +$212K 0.04% 184
2021
Q4
Sell
-3,352
Closed -$232K 531
2021
Q3
$232K Buy
3,352
+1,224
+58% +$86K 0.08% 145
2021
Q2
$147K Sell
2,128
-495
-19% -$33.1K 0.06% 165
2021
Q1
$170K Hold
2,623
0.08% 124
2020
Q4
$170K Buy
2,623
+491
+23% +$29.6K 0.08% 123
2020
Q3
$135K Buy
2,132
+1,197
+128% +$83K 0.08% 130
2020
Q2
$72K Sell
935
-432
-32% -$33.1K 0.05% 181
2020
Q1
$102K Sell
1,367
-87
-6% -$6.01K 0.09% 140
2019
Q4
$94K Buy
1,454
+7
+0.5% +$456 0.07% 169
2019
Q3
$92K Sell
1,447
-560
-28% -$36.6K 0.09% 158
2019
Q2
$136K Buy
2,007
+1,823
+991% +$120K 0.12% 137
2019
Q1
$11K Sell
184
-62
-25% -$4.12K 0.01% 422
2018
Q4
$15K Buy
+246
New +$17.2K 0.01% 364

Other funds holding GILD

Liberty Wealth Management's GILD Position: Q2 2026 in Review

Liberty Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,715 shares worth $239K. The position accounts for 0.03% of the portfolio, ranked #239.

Liberty Wealth Management first reported a position in GILD in Q4 2018 and has held it in 20 quarters since. The position peaked at $272K in Q3 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Liberty Wealth Management held 1,715 shares of Gilead Sciences worth $239K as of Q2 2026.
  • Liberty Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.03% of Liberty Wealth Management's portfolio in Q2 2026, its #239 holding.
  • Liberty Wealth Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 20 quarters since.
  • Liberty Wealth Management's Gilead Sciences position peaked at $272K in Q3 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Liberty Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.